What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
A National HIV Response Sustainability Assessment and Roadmap (Part A) was launched on Tuesday in Accra to serve as a guide towards securing long-term financing and national ownership of the country’s ...
A new study from researchers at Intermountain Health in Salt Lake City finds that a comprehensive program with a strong focus ...
It’s super effective after about 7 days of consistent use …”  “Have there been people who have used it and still got HIV?”  “Most people who take PrEP correctly don’t get HIV, but a small number might ...
The twice-yearly injectable drug, developed by US-based Gilead Sciences, has been shown in clinical trials to prevent more than 99 percent of HIV infections among high-risk groups. According to the ...
This is the Global Health Checkup, five of the week’s most important stories on outbreaks, medicine, science, and survival from around the world. This week: a breakthrough on the price of a new HIV ...
Additionally, two HIV medicines - emtricitabine with tenofovir disoproxil and dolutegravir - would be made available on a Practitioner’s Supply Order (PSO) for Post Exposure Prophylaxis (PEP). This ...
EXPERTS are proposing a ‘one-stop’ care model integrating services for HIV/AIDS and non-communicable diseases (NCDs), with a visible rise in HIV/Aids care quotations. Prof. George Ruhago, a principal ...
The discussions came at a pivotal moment. According to UNODC’s World Drug Report 2025, an estimated 64 million people suffered from a drug use disorder, a 13 per cent increase over the last ten years.
After 25 years as the Two x Two for AIDS and Art in Dallas, the event celebrates rebrands into a new beginning as amfAR ...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...